Please read and agree to the terms and conditions of this site.
@xconomy.com 5 years ago
In a Genentech Redux, Roche Pays $2.4B for Rest of Foundation Medicine
@xconomy.com 6 years ago
Biotech Roundup: ASCO Ahead, CAMP4’s Cash, Ambien Tweeting & More
@xconomy.com 6 years ago
Amgen Migraine Drug Gets FDA Nod, First in New Class of Medicines
@xconomy.com 6 years ago
Trump Pledges Lower Drug Prices, But Blueprint Is Short on Details
@xconomy.com 6 years ago
Histogen Treatment for Female Hair Loss Cleared for Clinical Testing
@xconomy.com 6 years ago
San Antonio Startup Adds Funding to Treat PTSD with Magnetic Field
@xconomy.com 6 years ago
United Therapeutics Reaches $141M Deal for PAH Drug Firm SteadyMed
@xconomy.com 6 years ago
Exact Sciences Beats Quarterly Forecasts, Sending Its Stock Price Up